Search for Clinical Trial Results
Familial Transthyretin Amyloidosis - 25 Studies Found
Status | Study |
Withdrawn |
Study Name: The Effect of an Antisense Oligonucleotide to Lower Transthyretin (TTR) Levels on the Progression of -Wild-type TTR Involving the Heart Condition: Amyloidosis Date: 2015-11-19 Interventions: Drug: Isis 420915/GSK 299872 Open label study in comparison to historic control. |
Recruiting |
Study Name: A Safety and Tolerability Study of an Investigational Drug, ALN-TTRSC02, in Healthy Subjects Condition: Transthyretin-mediated Amyloidosis (ATTR Amyloidosis) Date: 2016-05-18 Interventions:
|
Enrolling by invitation |
Study Name: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran) Condition: Amyloidosis Date: 2015-07-16 Interventions: Drug: Patisiran (ALN-TTR02) administered by intravenous (IV) infusion |
Active, not recruiting |
Study Name: Tolerability and Efficacy of a Combination of Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy Condition:
Date: 2013-03-12 Interventions: Drug: Tauroursodeoxycholic Acid and Doxycycline |
Completed |
Study Name: Burden of Disease Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers Condition:
|